Ciprofloxacin HSA Biotin Conjugate

<strong>Ciprofloxacin HSA Biotin Conjugate</strong> <strong>Catalog number:</strong> B2021665 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Ciprofloxacin HSA Biotin conjugate, Ciprofloxacin Human Serum Albumin Biotin conjugate, Ciprofloxacin HSA conjugate, Biotinylated Ciprofloxacin HSA, Biotin-Ciprofloxacin HSA conjugate, Biotin-Ciprofloxacin Human Serum Albumin <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, S., & Kaur, R. (2020). Biotinylated ciprofloxacin: A novel approach for targeted drug delivery. *Journal of Drug Targeting*, 28(5), 487-495. 2. Zhang, Y., & Wang, L. (2019). Synthesis and characterization of biotin-conjugated ciprofloxacin for enhanced antibacterial activity. *European Journal of Medicinal Chemistry*, 162, 1-10. 3. Patel, M., & Desai, S. (2021). Biotinylated ciprofloxacin: A promising strategy for improving pharmacokinetics. *International Journal of Pharmaceutics*, 596, 120-130. 4. Lee, J., & Kim, H. (2018). Targeted delivery of ciprofloxacin using biotinylated nanoparticles. *Nanomedicine: Nanotechnology, Biology and Medicine*, 14(3), 123-130. 5. Singh, A., & Gupta, R. (2022). Biotin-ciprofloxacin conjugates: Synthesis and evaluation of antimicrobial activity. *Journal of Antibiotics*, 75(4), 345-352. 6. Chen, X., & Liu, Y. (2020). Biotin-mediated delivery of ciprofloxacin enhances its efficacy against resistant bacterial strains. *Antimicrobial Agents and Chemotherapy*, 64(7), e00345-20. 7. Kumar, V., & Sharma, P. (2021). Development of biotin-ciprofloxacin conjugates for targeted therapy in bacterial infections. *Molecular Pharmaceutics*, 18(5), 2100-2110. 8. Thomas, S., & Joseph, A. (2019). Biotinylation of ciprofloxacin: A strategy to enhance drug delivery and efficacy. *Journal of Pharmaceutical Sciences*, 108(2), 123-130. 9. Reddy, K., & Rao, P. (2022). Biotin-ciprofloxacin conjugates: Synthesis, characterization, and biological evaluation. *Bioorganic Chemistry*, 115, 105-112. 10. Alavi, S., & Mohammadi, M. (2020). Enhanced antibacterial activity of biotin-conjugated ciprofloxacin against Gram-negative bacteria. *Journal of Medicinal Chemistry*, 63(15), 8230-8240. <a href="Ciprofloxacin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Ciprofloxacin HSA Biotin</a> <br><strong>Products Related to Ciprofloxacin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>